US 10259870
Anti-ANGPTL8 antibodies and uses thereof
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 10259870 (Anti-ANGPTL8 antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K2039/57, A61K39/39575